Lv51
1030 积分 2025-01-16 加入
The next generation of antibody–drug conjugates
1小时前
已完结
Flow Cytometric Analysis of Cell Division by Dye Dilution
7天前
已完结
Flow Cytometric Analysis of Cell Division by Dilution of CFSE and Related Dyes
7天前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
13天前
已完结
Harnessing multispecific antibodies for next-generation cancer treatments
13天前
已完结
Bystander activation in CD8 memory T cells is an innate program that is standalone from, yet influences TCR and TCR-driven responses 2259216
18天前
已完结
T cell engagers in autoimmune diseases
1个月前
已完结
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
1个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
2个月前
已完结
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
2个月前
已完结
皖公网安备34019202002308
